Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Recent Articles in Trials & Approvals

Gracell Reports 100% Minimal Residual Disease Rate for CAR-T in Myeloma Trial
Ascletis Enrolls 120 Patients for Phase III Trial of Glioblastoma Candidate
Elpiscience Starts Australian Trial of Anti-Immunosuppressive Candidate
Asieris Says Drug-Device Combination Effective for Cervical Lesions
AffaMed Begins China Phase III Trial of Pain Therapy for Cataract Surgery Pain
ChinaBio Event
September 20-21 | Shanghai
September 25-26 | Digital
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China